SCHEMBL5138201

SCHEMBL5138201

C=CC([C]=O)NC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11881482 0.80
SCHEMBL1446000 0.72
SCHEMBL8956995 0.70 TSHR (0.38)
SCHEMBL9285224 0.70
SCHEMBL1445859 0.70 TSHR (0.38)
SCHEMBL4243337 0.69
SCHEMBL170265 0.69
SCHEMBL6396783 0.67
SCHEMBL2210959 0.67
SCHEMBL2306569 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993994-A2 DEUTERATED HEPATITIS C PROTEASE INHIBITORS Vertex Pharmceuticals Incorporated (US) 2008-11-26 EP claimed
WO-2007109080-A2 DEUTERATED HEPATITIS C PROTEASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-09-27 WO claimed
EP-1993994-A2 DEUTERATED HEPATITIS C PROTEASE INHIBITORS Vertex Pharmceuticals Incorporated (US) 2008-11-26 EP disclosed
WO-2007109080-A2 DEUTERATED HEPATITIS C PROTEASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-09-27 WO disclosed